J. Travers

TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In Vivo

S. Ramaswamy, Sujatha Kumar, Srimoyee Ghosh, 2018, Molecular Cancer Therapeutics.

Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors

John N. Hutchinson, D. Ingber, Jianwei Che, 2022, Nature Communications.

A Phase I/II Study of AZD2811 Nanoparticles (NP) As Monotherapy or in Combination in Treatment-Naïve or Relapsed/Refractory AML/MDS Patients Not Eligible for Intensive Induction Therapy

Suzanne F. Jones, G. Fabbri, G. Borthakur, 2019, Blood.